The FINANCIAL -- The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for ...
The FINANCIAL -- On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar pharmaceutical industry bodies ...
The FINANCIAL -- Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the ...
The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) ...
